Drug Profile
Research programme: oleamide hydrolase inhibitors - Scripps Research Institute
Latest Information Update: 18 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action Fatty acid amide hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Insomnia
Most Recent Events
- 18 Apr 2002 No development reported - Preclinical for Insomnia in USA (unspecified route)
- 04 Sep 2000 New profile
- 04 Sep 2000 Preclinical development for Insomnia in USA (Unknown route)